CureVac
Develops drugs that allow the human body to fight various diseases
CureVac has raised €574M across 6 funding rounds from 3 investors, most recently a Early VC round in Jun 2020. Based in Tübingen, Germany; founded 2000; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€574M
€574,320,078
Funding rounds
6
Investors
3
distinct backers
Active since
2006-01
latest 2020-06
Funding by year
EUR raised per yearCureVac — funding by year — interactive chart.
Data table
| CureVac — funding by year | |
|---|---|
| 2005 | €22M |
| 2010 | €26M |
| 2012 | €80M |
| 2015 | €146M |
| 2020 | €300M |
Signals
High confidenceRaise-next likelihood9
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6 rounds raised
- ▼ Old (26y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-06-16 | Early VC | €300M | KFW | View deal → |
| 2015-11-01 | Series D+ | €100M | Baillie Gifford | View deal → |
| 2015-03-01 | Series D+ | €46M | — | View deal → |
| 2012-09-01 | Series D+ | €80M | — | View deal → |
| 2010-05-01 | Series C | €26M | — | View deal → |
| 2006-01-01 | Series B | €22M | DH Capital | View deal → |
Investors
3Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData